Free Trial
OTCMKTS:EAPIF

Euroapi (EAPIF) Stock Price, News & Analysis

C$0.84 0.00 (0.00%)
As of 10/15/2026

About Euroapi Stock (OTCMKTS:EAPIF)

Advanced

Key Stats

Today's Range
C$0.84
▼
C$0.84
50-Day Range
C$0.84
▼
C$1.17
52-Week Range
C$0.84
▼
C$3.59
Volume
N/A
Average Volume
1,575 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

EUROAPI is a France-based pharmaceutical company that develops, manufactures and markets active pharmaceutical ingredients (APIs), the substances responsible for the therapeutic effects of medicines. The company supplies APIs for use in a range of prescription and over-the-counter medicines, serving pharmaceutical companies and other healthcare customers.

Its portfolio includes chemical and biological APIs, as well as specialized products such as peptides and complex molecules. EUROAPI also provides contract development and manufacturing services, supporting customers from process development and scale-up through commercial production and regulatory supply.

EUROAPI was established in 2022 through the separation and listing of Sanofi’s API business. The company operates an international manufacturing and research network with sites in France, Germany, Italy, Hungary and the United Kingdom, serving customers in European and other global pharmaceutical markets.

AI Generated. May Contain Errors.

Receive EAPIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Euroapi and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EAPIF Stock News Headlines

Euroapi S.A. (EAPIF) Q2 2026 Earnings Call Transcript
“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 years
Dr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis. The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets. Watch his free video breakdown and see the five steps he outlines for investors.tc pixel
EUROAPI statement regarding the Brindisi site
Euroapi S.A. (EAPIF) Q4 2025 Earnings Call Transcript
See More Headlines

EAPIF Stock Analysis - Frequently Asked Questions

Euroapi's stock was trading at C$2.63 on January 1st, 2026. Since then, EAPIF shares have decreased by 67.9% and is now trading at C$0.84.

Shares of EAPIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:EAPIF
CIK
N/A
Fax
N/A
Employees
3,133
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:EAPIF) was last updated on 10/15/2026 by MarketBeat.com Staff.
From Our Partners